SCHEMBL8041250

SCHEMBL8041250

CC(C1CCCCC1)n1c(Br)nc2c(N)ncnc21

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 17/20 0.64
▸ ADORA1 P30542 16/20 0.64
▸ ADORA2B P29275 14/20 0.64
▸ ADORA3 P0DMS8 10/20 0.64
▸ PI4KA P42356 3/20 0.43
▸ PI4K2B Q8TCG2 3/20 0.43
▸ PI4K2A Q9BTU6 3/20 0.43
▸ PI4KB Q9UBF8 3/20 0.43
▸ PDE8B O95263 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8039378 0.84 ADORA2A (0.47) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL8046656 0.81 ADORA2A (0.44) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL8039416 0.78 ADORA2A (0.41) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL8043040 0.75 FBP1 (0.38) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL31061173 0.74 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL31061588 0.74 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3
SCHEMBL5732373 0.72 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL31061415 0.70 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA
SCHEMBL4954196 0.69 ADORA2A (0.61) ADORA2AADORA1ADORA2BADORA3
SCHEMBL29439771 0.68 ADORA2A (1.00) ADORA2AADORA1ADORA2BADORA3PI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060182-A2 NOVEL PRODRUGS FOR PHOSPHORUS-CONTAINING COMPOUNDS Metabasis Therapeutics, Inc. (US) 2000-12-20 — — EP disclosed
WO-1999045016-A2 NOVEL PRODRUGS FOR PHOSPHORUS-CONTAINING COMPOUNDS METABASIS THERAPEUTICS, INC. (US) 1999-09-10 — — WO disclosed
Send feedback